Motor, Vicdan KoksaldiEvirgen, OmerAksakal, MehmetInci, MelekOnlen, YusufOcak, Sabahattin2024-09-182024-09-1820101307-94412147-2939https://hdl.handle.net/20.500.12483/10476The aim of this study was to investigate the rates of HBsAg and anti-HCV seropositivity in women in reproductive age group who were applied to our provincial maternity hospital between January 01 and December 31, 2009. Levels of HBsAg and anti-HCV determined with chemiluminescence immunoassay (Architect i2000, Abbott, USA) method were evaluated retrospectively. A total of 5410 women out of 13065 women included in the study were followed-up for pregnancy. For HBsAg, 12969 samples were analyzed and 203 (1.6%) of these samples were positive; for anti-HCV, 12784 samples were analyzed and 55 (0.4%) of these samples were positive. HBsAg and anti-HCV serology were positive in 81 (1.5%) and in 16 (0.3%) of the pregnant women, respectively. Among age groups, a significant difference was determined for HBsAg positivity, but a significant difference was not observed for anti-HCV positivity. In conclusion, all pregnant women with positive serology should be educated for precaution during delivery. Hospitals should be controlled regularly.cainfo:eu-repo/semantics/closedAccessHepatitis Bhepatitis CpregnancyserologyArticle1625356WOS:000217180700002N/A